SLC5A2 and hydrops fetalis: The benefits of SGLT2 inhibitors therapy in HF can be attributed to multiple mechanisms, including the induction of an osmotic diuretic and natriuretic effect, which may reduce the severity of HF exacerbations (Lam et al., 2019).